Charter Oak Capital Management’s Ultralife ULBI Stock Holding History

Charter Oak Capital Management’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	–	–	837
2022 Q2	$0	Hold	500	–	–	﹤0.01%	1022
2022 Q1	$0	Hold	500	–	–	﹤0.01%	1037
2021 Q4	$0	Hold	500	–	–	﹤0.01%	930
2021 Q3	$0	Hold	500	–	–	﹤0.01%	884
2021 Q2	$0	Hold	500	–	–	﹤0.01%	877
2021 Q1	$0	Hold	500	–	–	﹤0.01%	843
2020 Q4	$0	Buy	+500	New	+$3.15K	﹤0.01%	757

Other funds holding ULBI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charter Oak Capital Management's ULBI Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Ultralife (ULBI) in Q3 2022, closing a stake of 500 shares.

Charter Oak Capital Management first reported a position in ULBI in Q4 2020 and held it in 7 quarters. The position peaked at $0 in Q2 2022. 30 funds tracked by Wall St. Rank hold ULBI as of Q3 2022.

Charter Oak Capital Management reported no remaining Ultralife position as of Q3 2022 after selling out during the quarter.
Charter Oak Capital Management sold 500 Ultralife shares in Q3 2022.
Charter Oak Capital Management first reported a position in Ultralife in Q4 2020 and held it in 7 quarters.
Charter Oak Capital Management's Ultralife position peaked at $0 in Q2 2022.
30 funds tracked by Wall St. Rank held Ultralife as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.